|
Availability:
|
Only a part of the volumes is accessible.
|
|
Licensed Period:
|
Elsevier DEAL Core Hybrid:
Vol. 103 (2023) -
ReadMe
|
|
Remaining Periods:
|
Homepage of the journal
|
|
Homepage(s):
|
|
|
Fulltext available since:
|
Volume 1
, H. 1
(1965)
|
|
Publisher:
|
American Society for Pharmacology and Experimental Therapeutics (ASPET) ; Elsevier
|
|
ZDB-ID:
|
1475030-2
|
|
E-ISSN(s):
|
1521-0111
|
|
P-ISSN(s):
|
0026-895x
|
|
Appearance:
|
Fulltext, online only
|
|
Costs:
|
subject to fee
|
|
Comment:
|
Fast Forward (publish-ahead-of-print) articles are freely available upon publication. 2025 Verlagswechsel zu Elsevier.
|
